Spanish National Research Council, University of Seville, Evgen Pharma deal

Evgen exercised a 2013 option to acquire exclusive, worldwide rights to 60 sulforaphane analogs from the council and university. Evgen will pay an upfront fee and potential milestones based on the dev...